<DOCUMENT>
<TYPE>EX-10.261
<SEQUENCE>5
<FILENAME>a2104577zex-10_261.htm
<DESCRIPTION>EXHIBIT 10.26.1
<TEXT>
<HTML>
<HEAD>

</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#03WDC1176_4">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<!-- TOC_END -->
<P ALIGN="RIGHT"><FONT SIZE=2><A
NAME="lc1177_exhibit_10.26.1"> </A>
<A NAME="toc_lc1177_1"> </A>
<BR></FONT><FONT SIZE=2><B>Exhibit&nbsp;10.26.1    <BR>  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="lc1177_amendment_to_the_distribution_agreement"> </A>
<A NAME="toc_lc1177_2"> </A>
<BR></FONT><FONT SIZE=2><B>AMENDMENT TO THE DISTRIBUTION AGREEMENT    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment to the Distribution Agreement ("AGREEMENT") is entered into as of April&nbsp;28, 1999 (the "Effective Date") by and between
MedImmune,&nbsp;Inc. a Delaware corporation, having its principal place of business at 35 West Watkins Mill Road, Gaithersburg, MD 20878 ("MEDIMMUNE") and Abbott International,&nbsp;Ltd., a
Delaware corporation, having its principal place of business at 200 Abbott Park Road, Abbott Park, IL 60064. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>WITNESSETH  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, MEDIMMUNE and Abbott International,&nbsp;Ltd. entered into a Distribution Agreement as of December&nbsp;1, 1997 (the "DISTRIBUTION AGREEMENT"). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS,
the parties desire to amend the DISTRIBUTION AGREEMENT. </FONT></P>

<P><FONT SIZE=2>1.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;DEFINITIONS</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>1.1</FONT></DT><DD><FONT SIZE=2>All
fully capitalized terms used in this AGREEMENT have the same meaning as in the DISTRIBUTION AGREEMENT, except as otherwise defined above. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>2.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;AMENDMENT</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>2.1</FONT></DT><DD><FONT SIZE=2>Section&nbsp;3.3
of the DISTRIBUTION AGREEMENT is amended to add the following Sections 3.3(f), 3.3(g), 3.3(h) and 3.3(i): </FONT></DD></DL>
</UL>
<UL>
<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;For
a period of two (2)&nbsp;years from the Effective Date of this AGREEMENT, the amount invoiced by MEDIMMUNE to ABBOTT under Section&nbsp;3.3(a)(i)(A) and
3.3(a)(i)(B) shall be as follows: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(A)</FONT></DT><DD><FONT SIZE=2>For
100 mg vials: (CONFIDENTIAL TREATMENT REQUESTED).
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(B)</FONT></DT><DD><FONT SIZE=2>For
50 mg vials: (CONFIDENTIAL TREATMENT REQUESTED). </FONT></DD></DL>
</UL>
</UL>
</UL>
<UL>
<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;The
amounts paid under Section&nbsp;3.3(f) shall be treated as being paid under Section&nbsp;3.3(a)(i)&nbsp;for the purpose of determining the credit due under
Section&nbsp;3.3(a)(ii) </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;With
respect to each vial for which ABBOTT is invoiced under Section&nbsp;3.3(a)(i)&nbsp;as modified by Section&nbsp;3.3(i), which is not sold by ABBOTT prior to
the expiration date therefor, by December&nbsp;15<SUP>th</SUP> of each calendar year, for each unsold vial that has reached the expiration date during the period from
October&nbsp;1<SUP>st</SUP> of the previous calendar year through September&nbsp;30<SUP>th</SUP> of the applicable calendar year, ABBOTT shall pay the price therefor under
Section&nbsp;3.2(a) using as NET SALES the weighted average of NET SALES of PRODUCT sold in the TERRITORY for the period from July&nbsp;1<SUP>st</SUP>through September&nbsp;30<SUP>th</SUP>
of the applicable calendar year, with the amount paid therefor under Section&nbsp;3.3(f) being credited against the amount due under this Section&nbsp;3.3(h). The payment under this
Section&nbsp;3.3(h) shall include a report with respect to expired vials for the applicable period. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;With
respect to each vial for which ABBOTT is invoiced under Section&nbsp;3.3(a)(i)&nbsp;as modified by Section&nbsp;3.3(f), within forty-five
(45)&nbsp;days following the end of each CALENDAR QUARTER, as part of the report under Section&nbsp;3.3(b), ABBOTT shall provide to MEDIMMUNE a written country-by-country
report of the inventory and sales of such vials.&#151; </FONT></P>

</UL>
</UL>

<P><FONT SIZE=2>3.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;EFFECT</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>3.1</FONT></DT><DD><FONT SIZE=2>The
DISTRIBUTION AGREEMENT is amended as provided hereinabove as of the date first above written in accordance with Secion 14.3 of the DISTRIBUTION AGREEMENT. All other items and
provisions of the DISTRIBUTION AGREEMENT shall be unaffected by this AGREEMENT. </FONT></DD></DL>
</UL>
<HR NOSHADE>
<!-- ZEQ.=1,SEQ=1,EFW="2104577",CP="MEDIMMUNE, INC.",DN="4",CHK=602611,FOLIO='blank',FILE='DISK021:[03WDC7.03WDC1177]LC1177A.;10',USER='WAVILES',CD=';4-MAR-2003;11:35' -->
<UL>
<UL>
</UL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN
WITNESS WHEREOF, the parties hereto have caused this AGREEMENT to be executed by their respective representatives hereunto duly authorized as of the day and year first above-written. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=2><FONT SIZE=2>ABBOTT INTERNATIONAL,&nbsp;LTD.</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=2><FONT SIZE=2>MEDIMMUNE,&nbsp;INC.<BR></FONT>
</TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="8%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>ROBERT L. PARKINSON, JR.</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Robert L. Parkinson, Jr.</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="8%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>MELVIN D. BOOTH</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Melvin D. Booth</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="8%"><FONT SIZE=2>Name:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2>Robert L. Parkinson, Jr.</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="8%"><FONT SIZE=2>Name:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2>Melvin D. Booth</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="8%"><FONT SIZE=2>Title:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2>President&nbsp;&amp; COO</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="8%"><FONT SIZE=2>Title:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2>President</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2><I>JOINDER  </I></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned, Abbott Laboratories, an Illinois corporation, hereby consents to this AGREEMENT and joins in the execution of this AGREEMENT for the purpose of
obligating itself to the obligations and undertakings of Abbott International,&nbsp;Ltd., as set forth in this AGREEMENT. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=2><FONT SIZE=2>ABBOTT LABORATORIES</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="43%"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="7%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="47%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>ROBERT L. PARKINSON, JR.</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Name: Robert L. Parkinson, Jr.<BR>
Title President&nbsp;&amp; COO</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="43%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=2,EFW="2104577",CP="MEDIMMUNE, INC.",DN="4",CHK=883837,FOLIO='blank',FILE='DISK021:[03WDC7.03WDC1177]LC1177A.;10',USER='WAVILES',CD=';4-MAR-2003;11:35' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="03WDC1176_4">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_lc1177_1">Exhibit 10.26.1</A></FONT><BR>
</UL>
<FONT SIZE=2><A HREF="#toc_lc1177_2">AMENDMENT TO THE DISTRIBUTION AGREEMENT</A></FONT><BR>

<!-- SEQ=,FILE='QUICKLINK',USER=YLEE,SEQ=,EFW="2104577",CP="MEDIMMUNE, INC.",DN="4" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
